DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Tandia M, Mhiri A, Paule B. et al.
Correlation between clinical response to sorafenib in hepatocellular carcinoma treatment and polymorphisms of P-glycoprotein (ABCB1) and of breast cancer resistance protein (ABCG2): monocentric study.
Cancer Chemother Pharmacol 2017;
79 (04) 759-766
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.